Predicting Hormonal Therapy Medication Discontinuation for Breast Cancer Patients using Structured Data in Electronic Medical Records.

Hormonal therapy (HT) reduces the risk of cancer recurrence and the mortality rate for patients with hormone-receptor-positive breast cancer. However, it is estimated that half of the patients fail to complete the standard 5-year adjuvant treatment protocol. We investigate the extent to which certain types of structured data in electronic medical records (EMRs), namely conditions, drugs, laboratory tests and procedures, as well as when such data is entered EMRs, can forecast HT discontinuation. Our experiments with EMR data from 2,251 patients showed that machine learning models based on these data types achieve fair performance (AUC of 0.65). More importantly, the performance was not statistically significantly different when fitting a model using all or only one feature type, suggesting that the model is robust to missing information in the EMR. ©2022 AMIA - All rights reserved.